Alexander Mark Schobel, Chief Innovation/Tech Officer at Aquestive Therapeutics, Inc. (AQST), bought 1,000 shares at $7.78 ($8K) on 2018-12-10, disclosed to the SEC on 2018-12-11.
Open-market purchase of $8k AQST by Chief Innovation/Tech Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| AQST | BUY | 2022-06-10 | $44K | — | Filing → |
| AQST | SELL | 2021-02-10 | $236K | — | Filing → |
| AQST | SELL | 2021-02-09 | $265K | — | Filing → |